echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > AJKD: Serum levels of polyubiquitinated PTEN in American Indians with type 2 diabetes are associated with decreased renal function

    AJKD: Serum levels of polyubiquitinated PTEN in American Indians with type 2 diabetes are associated with decreased renal function

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Fibrosis is a major factor in progressive chronic kidney disease (CKD), regardless of its etiology
    .


    Therefore, the mechanism supporting the occurrence of fibrosis is very important to understand the pathophysiological mechanism of CKD, and fibrosis markers may also be clinical biomarkers of CKD progression


    K27Polyub

    Method: This is an observational cohort study
    .


    Included are Indians (154 women, 80 men) living in the Southwestern United States who are suffering from or at high risk of diabetic nephropathy (DKD)


    Results: At baseline, the mean age was 42.
    8±10.
    5 (SD) years, the history of diabetes was 11.
    5±7.
    1 years, the mean arterial pressure was 90.
    5±9.
    5 mmHg, glycosylated hemoglobin 9.
    3±2.
    4%, GFR 152±45 ml/min, albumin : The median of the creatinine ratio is 38 mg/g (interquartile range 14-215)
    .


    64 (27.


    K27Polyub th th K27Polyub th th K27Polyub

    Table 1 The relationship between PTEN K27Polyub concentration and renal outcome and all-cause mortality

    Table 1 The relationship between PTEN K27Polyub concentration and renal outcome and all-cause mortality K27Polyub

    Table 2 The relationship between kidney morphometry and serum PTEN K27Polyub

    Table 2 The relationship between kidney morphometry and serum PTEN K27Polyub K27Polyub

    Figure 1 Distribution of K27 polyubiquitinated PTEN; A.
    Unconverted B.
    Log conversion (The x-axis unit is inverse log, indicating the actual level of serum PTEN K27Polyub )

    Figure 1 Distribution of K27 polyubiquitinated PTEN; A.
    Unconverted B.
    Log conversion (The x-axis unit is inverse log, indicating the actual level of serum PTEN K27Polyub ) K27Polyub

    Figure 2 The survival chart of serum PTEN K27Polyub quartile predicting renal prognosis; A.
    Renal failure ≥ 40% decrease B.
    Renal failure C.
    End-stage renal disease or death from any cause

    Figure 2 The survival chart of serum PTEN K27Polyub quartile predicting renal prognosis; A.
    Renal failure ≥ 40% decrease B.
    Renal failure C.
    End-stage renal disease or death from any cause K27Polyub

    Conclusion: Among American Indians with type 2 diabetes, higher serum PTEN K27Polyub is associated with decreased GFR and increased risk of renal failure
    .

    Among American Indians with type 2 diabetes, higher serum PTEN K27Polyub is associated with decreased GFR and increased risk of kidney failure
    .


    K27Polyub

    Original source:

    Looker HC, Lin C, Nair V,et al, Serum Level of Polyubiquitinated PTEN and Loss of Kidney Function in American Indians With Type 2 Diabetes.


    Serum Level of Polyubiquitinated PTEN and Loss of Kidney Function in American Indians With Type 2 Diabetes.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.